Smolin Sergey Alekseevich

• 2011-2017 – I. M. Sechenov First Moscow State Medical University (Sechenov University), specialty "Medical business".
• 2017 – 2019 – Clinical residency in the specialty "Oncology", GBUZ "MCSC named after A. S. Loginov" DZM.
• International educational programs: ESMO–The Christie Preceptorship on Lung Cancer (Manchester, 2019), ESMO Advanced Course on NTRK Gene Fusion (Lyon, 2019); Conversations in Oncology (Vienna, 2020).

Work experience:

• 2019-2021 – Junior researcher of the Scientific Department of General Oncology of GBUZ "MCSC named after A. S. Loginov" DZM.
• 2021–present – Head of the Scientific Department of MEDONK CLINIC 2 LLC.
• 2021–present – oncologist of the chemotherapeutic department of the State Medical Institution "MCSC named after A. S. Loginov" DZM.
• 2024–present – Assistant of the Department of Oncology and Oncosurgery of the Russian University of Medicine of the Ministry of Health of Russia.

Work experience in the department is more than 6 years.
Certificate in oncology — 2025.

Specialization and area of scientific interests:

• Personalized drug treatment of solid tumors, the study of molecular genetic characteristics of solid tumors and their impact on the choice of therapy.
• A regular participant in oncological consultations, specializing in the drug antitumor treatment of tumors of the chest organs.
• Active scientific and teaching activities.

Scientific activity:

• Author and co-author of more than 10 scientific publications in peer-reviewed journals indexed in PubMed, Scopus and Web of Science. 
• Permanent participant of Russian and international oncological conferences, speaker and moderator of scientific sessions.
• A dissertation for the degree of Candidate of Science is being prepared for defense on the topic "Optimization of therapeutic tactics of patients with lung cancer with the development of resistance to EGFR inhibitors", scientific supervisor - Corresponding Member of the Russian Academy of Sciences, prof. Zhukova L.G.

Professional membership:

• Member of the Russian Society of Clinical Oncology (RUSSCO) and the European Society of Medical Oncology (ESMO).